205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.34%
Revenue growth at 50-75% of NXPI's 7.80%. Martin Whitman would worry about competitiveness or product relevance.
7.29%
Gross profit growth under 50% of NXPI's 22.05%. Michael Burry would be concerned about a severe competitive disadvantage.
14.75%
Positive EBIT growth while NXPI is negative. John Neff might see a substantial edge in operational management.
14.68%
Positive operating income growth while NXPI is negative. John Neff might view this as a competitive edge in operations.
21.75%
Positive net income growth while NXPI is negative. John Neff might see a big relative performance advantage.
23.26%
Positive EPS growth while NXPI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
23.81%
Positive diluted EPS growth while NXPI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-1.04%
Share reduction while NXPI is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.63%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
9.10%
Dividend growth of 9.10% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
20.02%
OCF growth under 50% of NXPI's 145.10%. Michael Burry might suspect questionable revenue recognition or rising costs.
-7.07%
Negative FCF growth while NXPI is at 69.23%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
54.53%
10Y CAGR of 54.53% while NXPI is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
32.29%
5Y CAGR of 32.29% while NXPI is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
2.56%
3Y CAGR of 2.56% while NXPI is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
42.74%
OCF/share CAGR of 42.74% while NXPI is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
6.47%
OCF/share CAGR of 6.47% while NXPI is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
40.02%
3Y OCF/share CAGR of 40.02% while NXPI is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
99.29%
10Y net income/share CAGR of 99.29% while NXPI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
85.55%
Net income/share CAGR of 85.55% while NXPI is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
15.90%
3Y net income/share CAGR of 15.90% while NXPI is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
45.75%
Equity/share CAGR of 45.75% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
3.31%
Equity/share CAGR of 3.31% while NXPI is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
1.15%
Equity/share CAGR of 1.15% while NXPI is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
508.03%
Dividend/share CAGR of 508.03% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
370.06%
Dividend/share CAGR of 370.06% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
203.64%
3Y dividend/share CAGR of 203.64% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-11.01%
Firm’s AR is declining while NXPI shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
7.71%
Inventory growth of 7.71% while NXPI is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
1.81%
Asset growth of 1.81% while NXPI is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
4.09%
BV/share growth of 4.09% while NXPI is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
No Data
No Data available this quarter, please select a different quarter.
-3.80%
Our R&D shrinks while NXPI invests at 33.72%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
2.35%
SG&A declining or stable vs. NXPI's 30.58%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.